Results: This study included 406 patients with BRAF-mutated colorectal cancer, 253 (228 V600BRAF) of whom had localised disease and 153 (137 V600BRAF) with metastatic disease at the time of diagnosis. The gene discussed is BRAF; the disease is metastatic neoplasm.